Arrow Artboard Created with Sketch. Artboard Created with Sketch. Title Chevron Title Chevron Icon Facebook Icon Linkedin Icon Mail Contact Path Layer Icon Mail Positive Arrow Icon Print Business deals Takeda scares away investors with talk of acquiring Shire Purchase price could undermine the Japanese drugmaker's finances SHINYA ABE, Nikkei staff writer March 30, 2018 19:33 JST | Japan
TOKYO -- The announcement that
Takeda Pharmaceutical is mulling a bid for Irish drugmaker Shire has sent the Japanese company's shares diving.
Investors fear such a large acquisition would put the Japanese company under a heavy debt load and erode its otherwise healthy finances.
Take your reading anywhere with offline reading functions Never miss a story with breaking news alerts Customize your reading experience
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.
Accept & Continue